EurekAlert!12 天
Targeted alpha therapy as a new therapeutic strategy for treating metastatic melanoma. (IMAGE)
A newly developed astatine-211 (211At)-labeled peptide drug inhibits malignant melanoma cells by releasing alpha particles in the targeted cancer tissue.